Home > Insider Trading > Filing (0000899243-20-006982)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1552451	Myokardia Inc.	MYOK	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1413822	Anastasios Gianakakos	C/O Myokardia, Inc. 333 Allerton Avenue South San Francisco CA 94080	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-05-04	3,000	$1.51	77,968	No	4	M	Direct
Common Stock	Disposition	2018-05-04	1,700	$47.27	76,268	No	4	S	Direct
Common Stock	Disposition	2018-05-04	1,300	$47.95	74,968	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2018-05-04	3,000	$0.00	3,000	$1.51

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
123,235		2025-06-03	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The Form 4 filed by the Reporting Person on May 7, 2018 incorrectly reported that the Reporting Person exercised stock options to purchase 2,981 shares of Common Stock and sold 3,000 shares of Common Stock in a same day sale. This Form 4/A hereby amends such entry to state that the Reporting Person exercised 3,000 shares of Common Stock underlying the options and sold 3,000 shares of Common Stock in a same day sale.
Represents the weighted average sale price of the shares sold ranging from $46.80 to $47.70 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average sale price of the shares sold ranging from $47.85 to $48.10 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
25% of the shares subject to the option vested and became exercisable on June 4, 2016, and the remaining shares subject to this option vest and become exercisable in monthly installments through June 4, 2019, subject to the Reporting Person's continuous service to the Issuer.